Business Description
Clinica Baviera SA
ISIN : ES0119037010
Total Employee Number:
1,989Description
Clinica Baviera SA operates ophthalmological clinics. It is involved in the diagnosis, treatment, and monitoring of various types of ophthalmological disorders. It offers diagnosis and treatment for various eye problems such as long-sightedness, short-sightedness, astigmatism, cataracts and eye strain.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.95 | |||||
Equity-to-Asset | 0.47 | |||||
Debt-to-Equity | 0.55 | |||||
Debt-to-EBITDA | 0.77 | |||||
Interest Coverage | 72.91 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 5.86 | |||||
Beneish M-Score | -3.11 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15.7 | |||||
3-Year EBITDA Growth Rate | 16.1 | |||||
3-Year EPS without NRI Growth Rate | 12.3 | |||||
3-Year FCF Growth Rate | 6.6 | |||||
3-Year Book Growth Rate | 18.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 13.64 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 10.03 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 36.74 | |||||
9-Day RSI | 41.75 | |||||
14-Day RSI | 45.06 | |||||
3-1 Month Momentum % | 23.24 | |||||
6-1 Month Momentum % | 20.73 | |||||
12-1 Month Momentum % | 43.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.24 | |||||
Quick Ratio | 1.24 | |||||
Cash Ratio | 1.09 | |||||
Days Sales Outstanding | 9.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.85 | |||||
Dividend Payout Ratio | 0.57 | |||||
3-Year Dividend Growth Rate | 15.1 | |||||
Forward Dividend Yield % | 2.85 | |||||
5-Year Yield-on-Cost % | 2.81 | |||||
3-Year Average Share Buyback Ratio | 0.6 | |||||
Shareholder Yield % | 2.09 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | 20.09 | |||||
Net Margin % | 14.23 | |||||
EBITDA Margin % | 28.69 | |||||
FCF Margin % | 14.72 | |||||
OCF Margin % | 24.66 | |||||
ROE % | 41.29 | |||||
ROA % | 18.41 | |||||
ROIC % | 22.1 | |||||
3-Year ROIIC % | 12.95 | |||||
ROC (Joel Greenblatt) % | 47.69 | |||||
ROCE % | 35.28 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 19.86 | |||||
Forward PE Ratio | 18.25 | |||||
PE Ratio without NRI | 19.86 | |||||
Shiller PE Ratio | 33.3 | |||||
Price-to-Owner-Earnings | 14.65 | |||||
PEG Ratio | 1.05 | |||||
PS Ratio | 2.83 | |||||
PB Ratio | 7.02 | |||||
Price-to-Tangible-Book | 10.56 | |||||
Price-to-Free-Cash-Flow | 19.18 | |||||
Price-to-Operating-Cash-Flow | 11.45 | |||||
EV-to-EBIT | 15.18 | |||||
EV-to-EBITDA | 10.93 | |||||
EV-to-Revenue | 3.13 | |||||
EV-to-FCF | 19.57 | |||||
Price-to-GF-Value | 1.33 | |||||
Price-to-Projected-FCF | 1.34 | |||||
Price-to-DCF (Earnings Based) | 0.58 | |||||
Price-to-DCF (FCF Based) | 0.56 | |||||
Price-to-Median-PS-Value | 1.57 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.45 | |||||
Price-to-Graham-Number | 3.07 | |||||
Earnings Yield (Greenblatt) % | 6.59 | |||||
FCF Yield % | 4.72 | |||||
Forward Rate of Return (Yacktman) % | 18.33 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Clinica Baviera SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 308.54 | ||
| EPS (TTM) (€) | 2.739 | ||
| Beta | 1.3707 | ||
| 3-Year Sharpe Ratio | 1.57 | ||
| 3-Year Sortino Ratio | 3.72 | ||
| Volatility % | 26.37 | ||
| 14-Day RSI | 45.06 | ||
| 14-Day ATR (€) | 1.26803 | ||
| 20-Day SMA (€) | 56.78 | ||
| 12-1 Month Momentum % | 43.13 | ||
| 52-Week Range (€) | 39.8 - 61 | ||
| Shares Outstanding (Mil) | 16.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Clinica Baviera SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Clinica Baviera SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| EUR 1.570000 Cash Dividend | 2026-06-10 | 61.00 (+4.45%) | ||
| EUR 1.570000 Cash Dividend | 2025-06-11 | 42.50 (-0.23%) | ||
| EUR 1.570000 Cash Dividend | 2024-07-16 | 32.10 (+3.55%) |
Show
Entries
Clinica Baviera SA Frequently Asked Questions
What is Clinica Baviera SA(FRA:D9Z)'s stock price today?
The current price of FRA:D9Z is €55.00. The 52 week high of FRA:D9Z is €61.00 and 52 week low is €39.80.
When is next earnings date of Clinica Baviera SA(FRA:D9Z)?
The next earnings date of Clinica Baviera SA(FRA:D9Z) is .
Does Clinica Baviera SA(FRA:D9Z) pay dividends? If so, how much?
The Dividend Yield %  of Clinica Baviera SA(FRA:D9Z) is 2.85% (As of Today), Highest Dividend Payout Ratio of Clinica Baviera SA(FRA:D9Z) was 0.74. The lowest was 0.36. And the median was 0.63. The  Forward Dividend Yield % of Clinica Baviera SA(FRA:D9Z) is 2.85%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Clinica Baviera SA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers